Gene Therapy for HER-Positive Cancer (SENTRY-HER2)
Abroad (travel likely)RecruitingPHASE1, PHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
HER2 Expressing Solid Tumors
Locations
- Valkyrie Clinical Trials, Los Angeles, California, United States
- SCRI Denver DDU at HealthOne, Denver, Colorado, United States
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania, United States
- SCRI Oncology Partners, Nashville, Tennessee, United States